Cargando…
Drug Efflux Transporters Are Overexpressed in Short-Term Tamoxifen-Induced MCF7 Breast Cancer Cells
Tamoxifen is the first line drug used in the treatment of estrogen receptor-positive (ER+) breast cancer. The development of multidrug resistance (MDR) to tamoxifen remains a major challenge in the treatment of cancer. One of the mechanisms related to MDR is decrease of drug influx via overexpressio...
Autores principales: | Krisnamurti, Desak Gede Budi, Louisa, Melva, Anggraeni, Erlia, Wanandi, Septelia Inawati |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4769734/ https://www.ncbi.nlm.nih.gov/pubmed/26981116 http://dx.doi.org/10.1155/2016/6702424 |
Ejemplares similares
-
Curcumin for the Prevention of Epithelial-Mesenchymal Transition in Endoxifen-Treated MCF-7 Breast Cancer Cells
por: Paramita, P, et al.
Publicado: (2018) -
Differential expression of several drug transporter genes in HepG2 and Huh-7 cell lines
por: Louisa, Melva, et al.
Publicado: (2016) -
The Effect of Alpha Mangostin on Epithelial-Mesenchymal Transition on Human Hepatocellular Carcinoma HepG2 Cells Surviving Sorafenib via TGF-β/Smad Pathways
por: Adenina, Syarinta, et al.
Publicado: (2020) -
Hematological indices and their correlation with glucose control parameters in a prediabetic rat model
por: Krisnamurti, Desak Gede Budi, et al.
Publicado: (2022) -
Mesenchymal Stem Cell-Derived Extracellular Vesicles Increase Human MCF7 Breast Cancer Cell Proliferation associated with OCT4 Expression and ALDH Activity
por: Zakiyah, Nibras, et al.
Publicado: (2023)